Literature DB >> 7137732

Erythrocytosis in patients on long-term hemodialysis.

R J Shalhoub, U Rajan, V V Kim, E Goldwasser, J A Kark, L D Antoniou.   

Abstract

Erythrocytosis was seen in two men during maintenance hemodialysis therapy for end-stage renal disease secondary to apparent chronic glomerulonephritis. Nonrenal causes of erythrocytosis such as polycythemia vera, chronic hypoxemia, high-oxygen affinity hemoglobin, and hepatoma were excluded by appropriate clinical studies. A computed tomographic scan of the abdomen showed numerous renal cysts in each patient consistent with acquired cystic disease of end-stage kidneys. Peripheral serum erythropoietin levels were elevated as measured by sensitive radioimmunoassay. The findings suggest that the erythrocytosis is caused by an erythropoietic mechanism related to the diseased kidneys. A review of the literature failed to show previous reports of this clinical association.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137732     DOI: 10.7326/0003-4819-97-5-686

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  5 in total

1.  Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors:  David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

Review 2.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

Review 3.  Now a Nobel gas: oxygen.

Authors:  Joachim Fandrey; Johannes Schödel; Kai-Uwe Eckardt; Dörthe M Katschinski; Roland H Wenger
Journal:  Pflugers Arch       Date:  2019-11-22       Impact factor: 3.657

4.  Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report.

Authors:  Keiichi Ito; Takako Asano; Susumu Tominaga; Hidehiko Yoshii; Harutake Sawazaki; Tomohiko Asano
Journal:  Oncol Lett       Date:  2014-08-21       Impact factor: 2.967

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Roxadustat.

Authors:  David Czock; Frieder Keller
Journal:  Clin Pharmacokinet       Date:  2021-12-14       Impact factor: 5.577

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.